Clinical
0
As Congress Eyes Medicare Reform, ACG Is Representing the Clinical GI Perspective
0

Medicare physician reimbursement reform has been a longstanding policy priority for ACG, and after years of incremental fixes and stopgap solutions, ...

0
Management of Obesity: Review of Adjunctive Therapies and Clinical Management Pearls
0

Obesity remains one of the most prevalent costly diseases in the US and across the world. New therapies are available to treat obesity, and more therapies ...

0
Keto diet cut liver fat by 67% in a clinical trial
0

A very low-carbohydrate, high-fat diet may provide stronger metabolic benefits for people with obesity than either a Mediterranean diet or a low-fat diet, ...

0
Clinical Outcomes in Patients with Worrisome and High-Risk Pancreatic Cysts: A Prospective Cohort Study
0

Clinical Outcomes in Patients with Worrisome and High-Risk Pancreatic Cysts: A Prospective Cohort Study

0
Global Prevalence of Celiac Disease and Clinical Characteristics in the General Population: A Systematic Review and Meta-analysis
0

Celiac disease (CeD) is a global issue, with its burden detailed in a systematic review almost 8 years ago. Since then, new studies have emerged, prompting ...

0
P-47 – SOCIAL AND DEMOGRAPHIC PATTERNS IN INFLUENZA VACCINE UPTAKE AMONG 18–64 YEAR-OLDS WITH CLINICAL RISK CONDITIONS IN SCOTLAND: DESCRIPTIVE FINDINGS FROM THE 2025/26 SEASON
0

AbstractBackgroundSeasonal influenza vaccination is recommended for adults with clinical risk conditions due to increased risk of severe outcomes. In ...

0
Could Hydrogen-Rich Water Support Your Body’s Own GLP-1? Here’s What a Clinical Trial Found
0

Few hormones have attracted as much attention in weight-loss research as glucagon-like peptide-1, or GLP-1. This naturally occurring gut hormone helps ...

0
Monogenic and Polygenic Risk in Common Liver Diseases: Implications for Clinical Care
0

The burden of chronic liver disease is rapidly increasing worldwide, driven primarily by metabolic dysfunction–associated steatotic liver disease, metabolic ...

0
10-Year Follow-Up After Endoscopic Submucosal Dissection for Clinical T1a Undifferentiated-Type Early Gastric Cancer ≤2 cm Without Ulceration in a Nonrandomized, Single-Arm Confirmatory Trial (JCOG1009/1010)
0

Endoscopic submucosal dissection (ESD) is an organ-preserving approach used for early gastric cancer (EGC).1 JCOG1009/1010, a multicenter, single-arm, ...

Daily Deals
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart